Valuation: Caplin Point Laboratories Limited

Market Cap 20TCr 205.4Cr 178.35Cr 166.29Cr 152.76Cr 288.91Cr 292.08Cr 1.96TCr 766.38Cr 9.77TCr 771.33Cr 754.43Cr 32TCr P/E 2026
17.9x
P/E 2027 * 27.4x
Enterprise Value 20TCr 205.4Cr 178.35Cr 166.29Cr 152.76Cr 288.91Cr 292.08Cr 1.96TCr 766.38Cr 9.77TCr 771.33Cr 754.43Cr 32TCr EV / Sales 2026
5.23x
EV / Sales 2027 * 7.85x
Free-Float
26.39%
Yield 2026 *
-
Yield 2027 * 0.16%
1 day+0.23%
1 week-0.63%
Current month+2.19%
1 month+1.33%
3 months+48.13%
6 months+34.69%
Current year+39.92%
1 week 2,495.8
Extreme 2495.8
2,638.4
1 month 2,435.4
Extreme 2435.4
2,699
Current year 1,500.3
Extreme 1500.3
2,699
1 year 1,500.3
Extreme 1500.3
2,699
3 years 875.8
Extreme 875.8
2,699
5 years 575
Extreme 575
2,699
10 years 176.2
Extreme 176.2
2,699
Manager TitleAgeSince
Chief Executive Officer 71 28/03/2015
Director of Finance/CFO - 19/02/2016
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 27/01/2010
Director/Board Member - 05/11/2025
Director/Board Member 71 28/03/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.22%-0.63% - - 204.46Cr
-1.26%-0.64%+19.64%+72.44% 4.94TCr
-0.92%+3.48%+60.51%+127.32% 3.85TCr
-0.53%-1.49%-3.17%+18.69% 1.25TCr
-2.01%-1.43%+15.24%+68.89% 1.17TCr
-1.33%-0.95%+31.06%+132.74% 909.25Cr
-0.52%-8.57%+35.07%-16.37% 700.61Cr
+0.17%+2.31%+15.24%+34.04% 686.4Cr
-.--%+0.14% - - 678.76Cr
-0.68%-2.41%+7.53%+170.49% 660.23Cr
Average -0.65%+0.60%+22.64%+76.03% 1.65TCr
Weighted average by Cap. -0.59%+0.63%+29.09%+84.51%

Financials

2026 2027 *
Net sales 2.13TCr 22Cr 19Cr 18Cr 17Cr 31Cr 32Cr 213.51Cr 83Cr 1.06TCr 84Cr 82Cr 3.52TCr 2.49TCr 26Cr 23Cr 21Cr 19Cr 37Cr 37Cr 249.65Cr 98Cr 1.24TCr 98Cr 96Cr 4.12TCr
Net income 616.2Cr 6.48Cr 5.62Cr 5.24Cr 4.82Cr 9.11Cr 9.21Cr 62Cr 24Cr 308.03Cr 24Cr 24Cr 1.02TCr 712.75Cr 7.49Cr 6.51Cr 6.07Cr 5.57Cr 11Cr 11Cr 72Cr 28Cr 356.29Cr 28Cr 28Cr 1.18TCr
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,966
Date Price Change Volume
05/26/05 2,564.00 -0.31% 20,989
04/26/04 ₹2,571.90 +0.23% 57,214
03/26/03 ₹2,566.10 +1.96% 55,647
31/26/31 ₹2,516.80 -0.77% 52,768
30/26/30 ₹2,536.30 -2.94% 82,641
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,570.40INR
Average target price
2,505.00INR
Spread / Average Target
-2.54%

Quarterly revenue - Rate of surprise